Valuation: Gencurix Inc.

Market Cap 30.03B 20.7M 18.19M 16.98M 15.58M 29.16M 1.98B 29.88M 201M 78.72M 981M 77.71M 76.02M 3.39B P/E 2022
-1.86x
P/E 2023 -3.82x
Enterprise Value 35.66B 24.58M 21.6M 20.16M 18.5M 34.63M 2.35B 35.49M 239M 93.49M 1.17B 92.28M 90.28M 4.03B EV / Sales 2022
26.8x
EV / Sales 2023 34.6x
Free-Float
55.38%
Yield 2022 *
-
Yield 2023 -
1 day-5.34%
1 week-7.65%
Current month-36.51%
1 month-32.20%
3 months-40.43%
6 months-22.95%
Current year-9.74%
1 week 1,321
Extreme 1321
1,680
1 month 1,321
Extreme 1321
2,300
Current year 1,321
Extreme 1321
7,320
1 year 1,321
Extreme 1321
7,320
3 years 1,131
Extreme 1131
8,910
5 years 1,131
Extreme 1131
23,500
10 years 1,131
Extreme 1131
32,300
Manager TitleAgeSince
Chief Executive Officer 53 -
Chief Tech/Sci/R&D Officer 64 2014-12-31
Corporate Officer/Principal 61 2023-03-30
Director TitleAgeSince
Director/Board Member 53 -
Director/Board Member 61 2023-03-30
Director/Board Member 43 2023-09-12
Change 5-day change 1-year change 3-year change Capi.($)
-5.34%-7.65%-13.74%-53.95% 23.81M
+0.31%-4.43%+232.57%+269.22% 19.04B
-2.80%+3.48%-41.63%-25.88% 10.07B
-2.57%-4.41%+38.50%+15.62% 6.68B
-1.55%-1.55%+230.86%-26.45% 5.97B
+0.31%+4.14%-15.57%-20.65% 5.53B
0.00%+1.37%-43.35% - 4.41B
+0.34%+5.10%-21.46%-30.05% 4.26B
-0.33%-16.23%+70.56%+88.36% 4.15B
+2.54%+0.15%-18.58%-43.19% 2.69B
Average -0.91%-2.38%+41.82%+19.23% 6.28B
Weighted average by Cap. -0.64%-1.49%+87.83%+82.47%

Financials

2022 2023
Net sales 2.56B 1.76M 1.55M 1.45M 1.33M 2.49M 169M 2.55M 17.16M 6.71M 83.61M 6.62M 6.48M 289M 2.6B 1.79M 1.57M 1.47M 1.35M 2.53M 172M 2.59M 17.43M 6.82M 84.94M 6.73M 6.58M 294M
Net income -24.6B -16.95M -14.9M -13.9M -12.76M -23.89M -1.62B -24.48M -165M -64.48M -804M -63.65M -62.27M -2.78B -19.26B -13.27M -11.66M -10.89M -9.99M -18.7M -1.27B -19.17M -129M -50.49M -629M -49.84M -48.76M -2.18B
Net Debt 22.55B 15.54M 13.66M 12.75M 11.7M 21.9M 1.49B 22.44M 151M 59.11M 737M 58.35M 57.08M 2.55B 5.63B 3.88M 3.41M 3.18M 2.92M 5.47M 372M 5.61M 37.76M 14.77M 184M 14.58M 14.26M 636M
Logo Gencurix Inc.
Gencurix Inc. is a Korea-based company mainly engaged in the sale of medical equipments. In addition, the Company is involved in the manufacturing and sale of breast cancer test (BCT) kits, Korean genetic polymorphism diagnostic kits, lung cancer and colorectal cancer diagnostic kits. The BCT kits are used for analyzing the expression level of the cancer-related gene. The products are sold under the name of GenesWell.
Employees
-
Date Price Change Volume
26-07-28 1,400.00 -5.34% 129,973
26-07-28 ₩1,479.00 -5.92% 89,401
26-07-27 ₩1,572.00 -2.90% 61,841
26-07-24 ₩1,619.00 -3.00% 62,499
26-07-23 ₩1,669.00 +4.44% 90,565
  1. Stock Market
  2. Stocks
  3. A229000 Stock